Ampio Pharmaceuticals Statistics
Total Valuation
AMPE has a market cap or net worth of $113,536. The enterprise value is -$3.70 million.
| Market Cap | 113,536 |
| Enterprise Value | -3.70M |
Important Dates
The last earnings date was Monday, May 6, 2024, after market close.
| Earnings Date | May 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
AMPE has 1.14 million shares outstanding. The number of shares has increased by 10.11% in one year.
| Shares Outstanding | 1.14M |
| Shares Change (YoY) | +10.11% |
| Shares Change (QoQ) | +3.19% |
| Owned by Insiders (%) | 1.56% |
| Owned by Institutions (%) | 3.23% |
| Float | 1.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.03 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.36 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 14.53 |
Financial Efficiency
Return on equity (ROE) is -247.89% and return on invested capital (ROIC) is -250.30%.
| Return on Equity (ROE) | -247.89% |
| Return on Assets (ROA) | -145.21% |
| Return on Capital (ROIC) | -250.30% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.39M |
| Employee Count | 6 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -120,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.87% in the last 52 weeks. The beta is 2.14, so AMPE's price volatility has been higher than the market average.
| Beta (5Y) | 2.14 |
| 52-Week Price Change | -97.87% |
| 50-Day Moving Average | 0.21 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 35.38 |
| Average Volume (20 Days) | 3,015 |
Short Selling Information
The latest short interest is 32,904, so 2.90% of the outstanding shares have been sold short.
| Short Interest | 32,904 |
| Short Previous Month | 34,736 |
| Short % of Shares Out | 2.90% |
| Short % of Float | 2.95% |
| Short Ratio (days to cover) | 0.31 |
Income Statement
| Revenue | n/a |
| Gross Profit | -245,000 |
| Operating Income | -9.10M |
| Pretax Income | -8.63M |
| Net Income | -8.33M |
| EBITDA | -9.33M |
| EBIT | -9.46M |
| Earnings Per Share (EPS) | -$10.70 |
Balance Sheet
The company has $4.09 million in cash and $274,000 in debt, giving a net cash position of $3.82 million or $3.36 per share.
| Cash & Cash Equivalents | 4.09M |
| Total Debt | 274,000 |
| Net Cash | 3.82M |
| Net Cash Per Share | $3.36 |
| Equity (Book Value) | 3.36M |
| Book Value Per Share | 2.96 |
| Working Capital | 3.22M |
Cash Flow
| Operating Cash Flow | -8.56M |
| Capital Expenditures | n/a |
| Free Cash Flow | -8.56M |
| FCF Per Share | -$10.32 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AMPE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.11% |
| Shareholder Yield | -10.11% |
| Earnings Yield | -7,336.00% |
| FCF Yield | -7,542.98% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on September 12, 2023. It was a reverse split with a ratio of 1:20.
| Last Split Date | Sep 12, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |